The estimated Net Worth of Paul D Coombs is at least $152 Milion dollars as of 27 December 2018. Mr. Coombs owns over 150,000 units of Balchem stock worth over $151,762,761 and over the last 21 years he sold BCPC stock worth over $0. In addition, he makes $186,836 as Independent Director at Balchem.
Sign up
Mr. Coombs BCPC stock SEC Form 4 insiders trading
Paul has made over 4 trades of the Balchem stock since 2011, according to the Form 4 filled with the SEC. Most recently he bought 150,000 units of BCPC stock worth $207,000 on 27 December 2018.
The largest trade he's ever made was exercising 165,000 units of Balchem stock on 23 December 2011 worth over $1,519,650. On average, Paul trades about 4,535 units every 36 days since 2003. As of 27 December 2018 he still owns at least 925,552 units of Balchem stock.
You can see the complete history of Mr. Coombs stock trades at the bottom of the page.
Wallmine is a radically better financial terminal.
Sign up in seconds, it's free!
Wallmine is a radically better financial terminal.
Sign up in seconds, it's free!
Paul Coombs biography
Paul D. Coombs serves as Independent Director of the Company. From April 2005 until his retirement in June 2007, Mr. Coombs was the Executive Vice President of Strategic Initiatives for Tetra Technologies, Inc. (NYSE), an oil and gas services company; from May 2001 to April 2005, was its Executive Vice President and Chief Operating Officer and from January 1994 to May 2001 Mr. Coombs served as Tetra’s Executive Vice President – Oil & Gas.
What is the salary of Paul Coombs?
As the Independent Director of Balchem, the total compensation of Paul Coombs at Balchem is $186,836. There are 12 executives at Balchem getting paid more, with Theodore Harris having the highest compensation of $3,808,410.
How old is Paul Coombs?
Paul Coombs is 64, he's been the Independent Director of Balchem since 2010. There are 2 older and 10 younger executives at Balchem. The oldest executive at Balchem Corp. is Perry Premdas, 67, who is the Independent Director.
What's Paul Coombs's mailing address?
Paul's mailing address filed with the SEC is BALCHEM CORPORATION, 52 SUNRISE PARK ROAD, NEW HAMPTON, NY, 10958.
Insiders trading at Balchem
Over the last 21 years, insiders at Balchem have traded over $37,143,279 worth of Balchem stock and bought 47,350 units worth $1,702,145 . The most active insiders traders include Dino A Rossi, Frank Fitzpatrick oraz David F Ludwig. On average, Balchem executives and independent directors trade stock every 36 days with the average trade being worth of $2,396,094. The most recent stock trade was executed by Gunsteren Job Leonard Van on 31 July 2024, trading 7,750 units of BCPC stock currently worth $462,288.
What does Balchem do?
founded in 1967, balchem provides state-of-the-art solutions and the finest quality products for a range of industries worldwide. our company consists of four business segments: human nutrition & health; specialty products; animal nutrition and health and industrial products. balchem employs approximately 1,000 people worldwide who are engaged in many diverse activities, developing our company into chosen market leadership positions. visit our website at www.balchem.com to learn more about us and the exciting opportunities we have available!
What does Balchem's logo look like?
Complete history of Mr. Coombs stock trades at Balchem, CSI Compressco LP oraz Tetra Technologies
Balchem executives and stock owners
Balchem executives and other stock owners filed with the SEC include:
-
Theodore Harris,
Chairman of the Board, President, Chief Executive Officer -
Theodore L. Harris,
Chairman, CEO & Pres -
Martin Bengtsson,
Chief Financial Officer -
Scott Mason,
Vice President of Manufacturing and Supply Chain and Vice President and General Manager, Industrial Products -
William Backus,
Chief Accounting Officer -
Mark Stach,
General Counsel, Secretary -
Carl Martin Bengtsson,
CFO & Treasurer -
James C. Hyde,
Sr. VP and GM of Human Nutrition & Health -
Mark A. Stach,
Gen. Counsel & Corp. Sec. -
John Televantos,
Lead Independent Director -
Daniel Knutson,
Independent Director -
Matthew Wineinger,
Independent Director -
Perry Premdas,
Independent Director -
David Fischer,
Independent Director -
Paul Coombs,
Independent Director -
Joyce Lee,
Independent Director -
Dino A Rossi,
President and CEO -
Edward Mcmillan,
Director -
Matthew David Houston,
General Counsel, Secretary -
Frank Fitzpatrick,
Corp Controller & Treasurer -
Mary Theresa Coelho,
Chief Financial Officer -
Monica Vicente,
-
Olivier Rigaud,
-
Elaine R Wedral,
Director -
Richard Allen Bendure,
Chief Operating Officer -
Francis X Mcdermott,
Director -
Paul H Richardson,
VP Research and Development -
Dana E. Putnam,
VP and General Manager -
Cruce Patricia Siuta,
Vice President Technology -
Israel Sheinberg,
Director -
Winston A Samuels,
Vice President/GM Encapsulates -
Hoyt Jr Ammidon,
Director -
Kenneth P Mitchell,
Director -
Robert T Miniger,
VP/Human Resources -
David F Ludwig,
Vice President -
James C Hyde,
Sr. Vice President -
Kathleen B Fish,
-
Frederic Boned,
SVP/GM, Human Nutri. & Health -
Martin Luther Reid,
SVP Chief Supply Chain Officer -
Hatsuki Miyata,
EVP, Gen. Counsel & Secretary -
Gunsteren Job Leonard Van,
SVP and GM, Specialty Products -
Michael Robert Sestrick,
SVP & Chief Technology Officer -
Michael Brent Tignor,
SVP & Chief HR Officer -
Jonathan Harrison Griffin,
SVP & GM, Animal Nutrition